Hoth Therapeutics announces agreement to joint development for a SAV for the potential prevention of…
Hoth Therapeutics, Inc. announced that it has reached an agreement with Voltron Therapeutics, Inc. (Voltron) to form a joint venture entity, to be named HaloVax, to commence preclinical…
Read More...
Read More...
